The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2024 and forecasted to 2033
Market Growth Overview
- Current Market Size
- The genetic testing services market has seen significant growth, rising from $17.29 billion in 2023 to $19.19 billion in 2024, at a compound annual growth rate (CAGR) of 11%.
- This growth is driven by increasing demand for personalized and precision medicine, a higher prevalence of genetic disorders, high demand for prenatal testing, increasing population, and greater awareness and education.
- Future Market Projections
- The market is projected to reach $29.47 billion by 2028, with a CAGR of 11.3%.
- Key factors driving this future growth include the rising demand for non-invasive prenatal testing (NIPT), the rise of pharmacogenomics, a growing focus on preventive healthcare, increased direct-to-consumer (DTC) testing, and an emphasis on rare diseases and personalized therapies.
Drivers of Market Growth
Increasing Prevalence of Genetic Disorders
- Genetic Disorders Overview
- Genetic disorders are caused by abnormalities in an individual’s DNA, leading to physical or developmental issues.
- Factors such as increased awareness, improved diagnostic techniques, expanded genetic screening, and consanguineous marriages contribute to the rising prevalence of genetic disorders.
- Market Impact
- For example, according to the WHO, congenital diseases cause approximately 240,000 baby deaths globally within 28 days of birth each year.
- The CDC reports that about 6,000 babies are born with Down syndrome in the U.S. annually, or about 1 in every 700 babies.
- The growing prevalence of these disorders is driving demand for genetic testing services.
View More On The Genetic Testing Services Market Report 2024 – https://www.thebusinessresearchcompany.com/report/genetic-testing-services-global-market-report
Key Players in the Market
- Major Companies
- Leading companies in the market include F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Laboratory Corporation of America Holdings (LabCorp), Quest Diagnostics Incorporated, and Eurofins Scientific SE.
Technological Innovations
Advancements in Cancer Screening Tests
- Cancer Screening Innovations
- Major companies are developing advanced cancer screening tests to enhance accuracy, expand testing capabilities, and improve patient outcomes.
- These tests aim to detect cancer or precancerous conditions early, making treatment more effective.
- Case Study: Prenetics Group Limited
- In June 2022, Prenetics launched ColoClear, a non-invasive stool DNA test in Hong Kong for early colorectal cancer detection.
- ColoClear combines advanced stool DNA technology with a fecal immunochemical test (FIT), offering a convenient alternative to colonoscopy with high sensitivity.
Strategic Acquisitions
Myriad Genetics Expands Through Gateway Genomics Acquisition
- Acquisition Details
- In November 2022, Myriad Genetics acquired Gateway Genomics for $67.5 million.
- This acquisition expands Myriad’s capabilities in women’s health and oncology testing, providing more comprehensive and personalized genetic testing solutions.
- Company Background
- Gateway Genomics LLC is a U.S.-based genetics company specializing in genetic testing services, enhancing Myriad’s offerings in the market.
Market Segmentation and Regional Insights
Market Segmentation
- By Type
- Predictive Testing
- Carrier Testing
- Prenatal Testing
- Newborn Screening
- Other Types
- By Disease
- Cancer Disease
- Metabolic Disease
- Cardiovascular Disease
- Other Diseases
- By End User
- Diagnostic Laboratories
- Hospitals and Clinics
- Academic Institutes and Research Centers
- Other End Users
Regional Dynamics
- Largest Market: North America
- North America was the largest region in the genetic testing services market in 2023, driven by advanced healthcare infrastructure and high adoption of genetic testing technologies.
Conclusion
- The genetic testing services market is poised for continued rapid growth, driven by the rising demand for personalized medicine, advanced cancer screening tests, and strategic acquisitions.
- Key players are focusing on technological innovations and expanding their capabilities to meet the growing demand for genetic testing services.
- With North America leading the market and significant growth potential in other regions, the genetic testing services market is set to transform healthcare diagnostics and personalized medicine globally.
Request A Sample Of The Global Genetic Testing Services Market Report 2024:
https://www.thebusinessresearchcompany.com/sample_request?id=15385&type=smp